These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26420051)

  • 1. Development of Personalized Molecular Therapy for Acute Myeloid Leukemia.
    Engen CB; Hajjar E; Gjertsen BT
    Curr Pharm Biotechnol; 2016; 17(1):20-9. PubMed ID: 26420051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
    Daver N; Cortes J; Kantarjian H; Ravandi F
    Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision therapy for acute myeloid leukemia.
    Yang X; Wang J
    J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia.
    Bohl SR; Bullinger L; Rücker FG
    Expert Rev Hematol; 2018 May; 11(5):361-371. PubMed ID: 29543073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
    Miyamoto K; Minami Y
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future prospects of therapeutic clinical trials in acute myeloid leukemia.
    Khan M; Mansoor AE; Kadia TM
    Future Oncol; 2017 Mar; 13(6):523-535. PubMed ID: 27771959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
    Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
    Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
    Naqvi K; Konopleva M; Ravandi F
    Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
    Kim TK; Gore SD; Zeidan AM
    Semin Hematol; 2015 Jul; 52(3):172-83. PubMed ID: 26111464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia.
    Ricciardi MR; Mirabilii S; Licchetta R; Piedimonte M; Tafuri A
    Adv Biol Regul; 2017 Aug; 65():36-58. PubMed ID: 28549531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards precision medicine for AML.
    Döhner H; Wei AH; Löwenberg B
    Nat Rev Clin Oncol; 2021 Sep; 18(9):577-590. PubMed ID: 34006997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontline treatment of AML in adults].
    Miyamoto T; Kikushige Y; Yoshimoto AG
    Rinsho Ketsueki; 2017; 58(10):1884-1894. PubMed ID: 28978829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction in Acute Myeloid Leukemia - Implications for Novel Therapeutic Concepts.
    Konig H; Santos CD
    Curr Cancer Drug Targets; 2015; 15(9):803-21. PubMed ID: 26278711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
    Kopmar NE; Estey EH
    Clin Adv Hematol Oncol; 2019 Oct; 17(10):569-575. PubMed ID: 31730583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
    Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
    Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine.
    Casado P; Cutillas PR
    Mol Cell Proteomics; 2023 Apr; 22(4):100517. PubMed ID: 36805445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Newcombe AA; Gibson BES; Keeshan K
    Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.